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ABSTRACT
The Effects Of A Uniformly Weighted Exercise Suit On Biomarkers Of Bone Turnover
In Response To Aerobic Exercise In Postmenopausal Women With Low Bone Density
Haley Frances Terndrup

Current options for maintaining or slowing aging-related bone mineral density
(BMD) loss in postmenopausal women primarily include pharmaceutical agents. More
recently, physical activity and exercise have been suggested as highly effective, low cost
alternatives. Weighted aerobic exercise, utilizing load carriage systems (LCS), is known
to increase the gravitational forces impacting bone, creating a higher osteogenic stimulus
than standard aerobic exercise. In response to the positive research on aerobic exercise
with well-designed LCS, Dr. Lawrence Petrakis, MD, developed a unique 5.44 kg
uniformly weighted exercise suit. This study aimed to examine the effects of the
uniformly weighted exercise suit on serum biochemical markers of bone formation
(Amino-Terminal Propeptide of Type 1 Collagen [P1NP]; Carboxy-Terminal Propeptide
of Type 1 Collagen [P1CP] and resorption (Carboxy-Terminal Telopeptide of Type 1
Collagen [CTX]) in response to submaximal aerobic exercise in postmenopausal women
with low bone density. Nine volunteer, sedentary to lightly active, healthy
postmenopausal women (Age: 58.7±1.1 years, BMI: 28.2±1.0, BMD T-score: -1.2±0.5)
participated in this within-subjects study, wherein each participant exercised under two
counterbalanced conditions (aerobic exercise with [ES] or without [NS] the exercise suit).
During each condition, participants walked on a treadmill at 65%-75% of their agepredicted maximum heart rate until they reached their goal caloric expenditure (400kcal).
There was a seven-day washout period between sessions. Serum was processed using
ELISA protocols to investigate the change in biomarker at 24 and 72 hours post exercise,
relative to baseline. The results indicated, when compared to the NS condition, the ES
condition elicited a greater positive change in P1CP at 24 hours (P<0.05). During the NS
condition, CTX increased, relative to baseline, at 24 hours following exercise (P<0.05),
while there was no significant variance in CTX following the ES condition (P>0.05).
There was no effect of condition on P1NP at any time point (P>0.05). In sum,
submaximal aerobic exercise while wearing the uniformly weighted exercise suit elicited
an antiresorptive effect on bone collagen resorption with a simultaneous increase in bone
collagen formation 24 hours post exercise.

Key Words: Weighted Exercise Suit, Biomarkers, Bone Turnover, Formation,
Resorption, Postmenopausal, Osteoporosis, Low Bone Density, Aerobic Exercise
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Chapter I
INTRODUCTION

Statement of the Problem
As the human body ages, bones become more fragile and porous leading to
osteoporosis. This decline in both density and quality compromises the structural
integrity of bone, greatly increasing the risk for fracture (Clarke, 2008). Traditionally,
pharmaceutical interventions have been the primary method in the treatment of
osteoporosis. Studies have shown that modern antiresorptive and anabolic medicines
effectively lower the risk of fracture by either stimulating new bone growth by increasing
bone modeling, or by strengthening the already existing skeleton (Lindsay et al., 2006;
Stepan, Alenfeld, Boivin, Feyen, & Lakatos, 2003). While effective, these drugs have
detrimental side effects, high costs, and provide inconsistent results when tested (Cosman
et al., 2014).
More recently, physical activity and exercise have been suggested as effective,
low cost alternatives to maintain and potentially increase bone mineral density (BMD) in
postmenopausal women. Based on these findings, exercise is recommended as an
alternative treatment modality. The most commonly prescribed exercise for strengthening
bones is high intensity, high impact resistance training. Although effective, this type of
training is associated with increased risk of fracture and decreased quality of life due to
injury (Martyn-St James & Carroll, 2006). Recently, aerobic exercise has been indicated
as a lower risk alternative method of loading the skeleton when compared with high
intensity impact training (Alghadir, Aly, & Gabr, 2014; Block, Genant, & Black, 1986;
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N. E. Lane et al., 1986; Nilsson, Andersson, Havdrup, & Westlin, 1978; Rutherford,
1997; Talmage, Stinnett, Landwehr, Vincent, & McCartney, 1986), but is not as
effective. However, weighted aerobic exercise, utilizing load carriage systems (LCS),
increases the gravitational forces impacting the bone creating a higher osteogenic
stimulus than standard aerobic exercise. LCS also allow for the forces to be delivered in a
more gradual manner, rather than at the higher rate produced by resistance training
(Klentrou, Slack, Roy, & Ladouceur, 2007; Kohrt, Ehsani, & Birge, 1997; Milliken et al.,
2003; Snow, Shaw, Winters, & Witzke, 2000; Tosun, Bolukbasi, Cingi, Beyazova, &
Unlu, 2006). Currently, there are several LCS designs (backpacks, front packs, double
packs, weighted vests, hand and ankle weights, etc.), which require users to carry larger
weight amounts in singular locations around the body. These site-specific designs may
prove to be problematic when utilized to enhance aerobic exercise (Knapik, Harman, &
Reynolds, 1996), and may result in reduced performance, such as imbalance, shoulder
and back pain, and/or kyphosis. A more universal distribution of the weight around the
whole body has the potential to enhance the likelihood of completing the exercises in a
safe and effective manner (Curry et al., 2015).
In response to the positive research on aerobic exercise with well-designed LCS,
Dr. Lawrence Petrakis, MD, developed a 5.44 kg uniformly weighted exercise suit,
consisting of a front zip jacket and drawstring pants. The exercise suit is made from a
flexible fabric, called AthlotexTM, which combines biaxial stretching, breathability, and
flexibility to accommodate different body compositions.
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Statement of the Purpose and Research Hypotheses
The purpose of this study was to examine the effects of a uniformly weighted
exercise suit on biochemical markers of bone formation and resorption in response to
aerobic exercise in postmenopausal women with osteoporosis. We hypothesized the
following:
When compared to the non-suit condition, wearing the uniformly weighted exercise suit
during submaximal aerobic exercise will elicit a greater:
1. Positive change in P1NP at 24 and 72 hours post exercise relative to baseline.
2. Positive change in P1CP at 24 and 72 hours post exercise relative to baseline.
3. Negative change in CTX at 24 and 72 hours post exercise relative to baseline.

Delimitations
This study was delimited to the following parameters:
1. Only 9, sedentary to lightly active, female members of the Cal Poly and San Luis
Obispo communities between the ages of 45-65 years old and with low bone
density as assessed by DXA, were recruited as participants.
2. Only participants who met the sizing measurement specifications of the uniformly
weighted exercise suit were recruited for this study.
3. Physical activity during the duration of the study was self-reported using the
International Physical Activity Questionnaire (IPAQ).
4. Nutritional information was gathered and self-reported using the Automated SelfAdministered 24-hour Dietary Recall (ASA24).
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5. Body composition, bone mineral density, T-score, and Z-score were determined
using Dual X-ray Absorptiometry (DXA).

Assumptions
The study was based on the following assumptions:
1. It was assumed that all participants honestly self-reported medications and health
history information so as to not avoid exclusion from this study.
2. It was assumed that research assistants followed every protocol outlined in this
study.

Limitations
The study was limited by the following factors:
1. Psychological state and motivation may have affected the participant’s activity
level outside of testing sessions.
2. There was limited funding for this project.
3. Sizing measurements of the suit limited participant involvement and increased
exclusion criteria.

Definition of Terms
Aerobic exercise: a type of physical activity using large muscle groups and is maintained
continuously in a rhythmic nature; this type of exercise overloads the heart and lungs to
increase cardiorespiratory fitness

4

Amino-terminal of the propeptides of type 1 collagen (P1NP): biochemical marker of
bone formation
Anabolic agent: a class of pharmacological medication that acts by directly stimulating
bone formation, and reducing the risk of fracture
Antiresorptive agent: a class of pharmacological medication used in the prevention and
treatment of osteoporosis
Biochemical markers of bone turnover: cellular and extracellular components of the
skeletal matrix that can be measured in serum or urine; used to predict bone growth or
loss and fracture risk
Bone: major structural connective tissue and support for the human body
Bone mineral content (BMC): the mass of the mineral contained in an entire bone in
grams (g); the mass per unit bone length in grams per centimeter (g/cm)
Bone mineral density (BMD): the amount of mineralized tissue; amount per volume of
bone
Calcitonin: a polypeptide hormone that inhibits the resorptive activity of osteoclasts
Calcium: an essential mineral that’s major role is in the development and maintenance of
the healthy skeleton
Carboxy-terminal of the propeptides of type 1 collagen (P1CP): biochemical marker of
bone formation
Carboxy-terminal telopeptides of type 1 collagen (CTX): biochemical marker of bone
resorption
Collagen: the main structural protein found in human connective tissue
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Dual energy x-ray absorptiometry (DXA): a diagnostic test used to measure and assess
BMD at various sites of the skeleton using a low dose radiation exposure
Estrogen: steroid hormones controlling female sexual development; directly affects the
level of bone mass via estrogen receptors in bone that reduce the rate of bone resorption
and bone loss.
Exercise: a form of physical activity; pre-planned, structured, and repetitive bodily
movement purposefully done to maintain or improve the physical fitness level of the
participant
Formation: see osteogenesis
Fracture: the complete or incomplete breakage of bone
Heart rate: The number of heart beats per minute expressed as beatsminute-1 (bpm)
Hormone/Estrogen therapy: a general term for all types of estrogen replacement therapy
generally prescribed for women after menopause
Load carriage systems (LCS): systems used to enhance the comfort and efficiency of load
carriage, such as backpacks and shoulder straps
Load training: physical training while wearing additional external load
Metabolism: the biochemical processes occurring within a living cell or organism that are
necessary for the maintenance of life
Modeling: the skeletal process that occurs during the increased rate of bone mass
Normal bone mass: bone mineral density within 1 SD of the mean for normal young
adults
Osteoblasts: the cells responsible for secretion of the bone matrix
Osteoclasts: multinucleated cells that dissolve bone tissue
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Osteoid: unmineralized, organic part of the bone matrix that is formed prior to maturation
of the bone tissue
Osteogenesis: the formation of bone tissue
Osteopenia: low bone mass; bone mineral density between -1.0 and -2.5 SD below the
mean for young normal adults
Osteoporosis: a chronic, progressive disorder in which the bones become more porous,
brittle, and are at an increased risk for fracture; characterized by deterioration of
microarchitecture and bone strength; bone mineral density of -2.5 SD below the young
normal mean
Peak bone mass: the total bone mass amassed during young adulthood
Physical activity: any bodily movement produced by the contraction of skeletal muscle
resulting in the increase of energy expenditure over resting expenditure
Remodeling: the continuous coupled process of bone formation and resorption after the
termination of growth
Resistance training: a form of physical activity designed to improve muscular fitness
through the exercising of a muscle or muscle groups against an external resistance
Resorption: the decrease in bone mass via pathological or physiological means
Serum (blood): blood plasma from which the clotting factor has been removed
Standard deviation (SD): a measure of the variation of the distribution
T-score: (Measured BMD – Young adult mean BMD) / young adult standard deviation;
the number of SD above or below the mean for young normal adults of the same sex
Turnover: refers to the total volume of bone that is resorbed and formed over a period of
time; can be estimated by measuring biochemical markers of bone formation
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Vitamin D: a fat-soluble compound that is ingested from plant and animal sources; when
activated in the liver and kidney, vitamin D promotes calcium absorption and bone mass;
when taken as a replacement, it may increase the muscular strength and decreases risks
for falling
Wolff’s Law: theory postulated by Julius Wolff in the 19th century stating that bone will
adapt to the load under which it is placed
Z-score: (Mean BMD – Age matched mean BMD) / age matched standard deviation; the
number of SD above or below the mean for persons of the same age and sex
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Chapter II
LITERATURE REVIEW

With the average age of the world’s population increasing at an exponential rate,
the population of adults over the age of 65 years will double between 2008 and 2040.
This rise in population will lead to an increase in the number of individuals with
osteoporosis and an increase in the number of fractures (Cauley, 2013). Osteoporosis, a
disorder of the skeletal system, is characterized by progressive loss of bone mineral
density (BMD), compromised microarchitecture, and an increased susceptibility to
fracture (Shan, Xian, Li, Xiang, & Yuan, 2013). Affecting nearly 50% of women and
25% of men over the age of 50, osteoporosis ranges from asymptomatic to debilitating
and significantly decreasing the person’s quality of life (Rosen, 2005). In the United
States, there are 1.5 million osteoporotic fractures per year, which impose direct and
indirect annual medical costs of nearly $18 billion (Gabriel et al., 2002). Even if the
fracture rate stabilizes, the greater aging population projects an increase in the number of
fractures and associated costs (Burge et al., 2007).
Vertebral fractures are the most common osteoporotic fracture (Cauley, 2013),
potentially causing pain, loss of height, kyphosis or lordosis. Multiple fractures to the
vertebral column can lead to more debilitating problems, such as restrictive lung disease,
alterations of the abdominal anatomy, and discomfort of the digestive system (Nieves,
Mosner, & Silverstein, 2012). Hip fractures, as well as radial fractures, are most often the
result of a fall. Mortality rate following fracture is a major consequence of osteoporosis,
with roughly 24% of patients with hip fracture dying within the first year. In addition,
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emotional morbidity in the form of reclusiveness, depression, and fear of additional
fractures may accompany osteoporosis (Burge et al., 2007; Cauley, 2013; J. M. Lane,
Riley, & Wirganowicz, 1997; Nieves et al., 2012) and significantly reduce a patient’s
health related quality of life. Furthermore, osteoporosis related fracture impose a
substantial burden of disability and cost (Cauley, 2013) on postmenopausal women and
older men.
The decline in bone formation that is typically associated with aging is
attributable to changes both in physical activity levels and estrogen reduction. To fully
understand the effect of osteoporosis on bone metabolism, we have to first understand the
mechanisms by which bone turnover occurs and second, understand how current
treatment options affect these processes.

Bone Turnover Mechanisms
Wolff’s Law
Wolff’s law, established in 1892, proposes that when a bone is subject to
mechanical loading causing it to bend, bone structure is modified by the creation of new
bone within the existing concave portion of the bone, and resorption in the existing
convex region (Sinaki, 1989). Wolff suggested that bone growth and remodeling occur in
response to the forces placed upon it, implying that bone mass reaches an equilibrium
point, which is suited to the amount of loading routinely imposed upon it. While
investigating the pathology of osteoporosis, several studies on animals and humans have
illustrated that mechanical stress and strain on bones, resulting from increased muscle
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pressure rather than tension assist in the prevention of osteopenia and osteoporosis
(Abramson, 1948; Gillespie, 1954; Whedon, Deitrick, & Shorr, 1949).

Bone Modeling
Bone modeling is defined as bone formation by osteoblasts without prior bone
resorption by osteoclasts, resulting in an increase in bone mass (Clarke, 2008).
Osteoblasts, which are responsible for synthesizing new bone matrix, respond differently
to various hormonal, mechanical, or cytokine signals (Clarke, 2008; Hadjidakis &
Androulakis, 2006). These cells function in cluster groupings along the bony surface on
which they are producing and rebuilding. They originate from undifferentiated stem cells,
which have the potential to develop into a variety of mature cell types. Oftentimes,
osteoblast cells that have finished laying down the bony matrix end up entrapped within
this new bone matrix, further differentiating into osteocytes. Those that do not end up
trapped, remain on the bone surface and become flat, lining cells (Hadjidakis &
Androulakis, 2006).
There are 3 phases of bone formation, which cumulate in the mineralization and
hardening of the original bone matrix. First, osteoblasts produce osteoid by rapidly laying
down collagen. Second, the mineralization rate increases to equal the synthesis of
collagen. During the third stage, collagen synthesis declines while mineralization
continues until the osteoid fully mineralizes. In healthy adult bone, production and
maturation of the osteoid matrix occurs at the same rate as the mineralization process
(Hadjidakis & Androulakis, 2006).
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Bone Remodeling
Bone remodeling is the process by which bone is reintroduced in order to
maintain and strengthen existing mineral homeostasis (Clarke, 2008). Osteoclasts are
bone-lining cells responsible for bone resorption. By creating an acidic environment,
osteoclasts dissolve the bone mineral content (BMC) and compromise the strength of the
existing bone. To complete the process of resorption, osteoclasts release enzymes to
remove the remaining collagen bone matrix. Osteoclast activity is highly regulated by a
number of factors, predominantly by the receptor activator of NF-𝛋B ligand (RANKL).
This protein, produced by osteoblasts and their precursor cells, has been shown to exert
its effects on osteoclasts and their precursors through an interaction with the surface
receptor RANK. The interaction between RANKL and RANK triggers the formation of
signaling pathways involved in differentiation, activation, and survival of osteoclasts,
ultimately leading to an increase in the bone resorption rate. Osteoprotegerin (OPG) is
secreted by osteoblasts and protects bone by helping balance the effect of
RANKL/RANK interaction. OPG binds to RANKL preventing the ligand from
interacting with and binding to its receptor on the surface of osteoclasts. Several
homeostatic mechanisms, hormones and cytokines, balance and temperate the production
of RANKL versus OPG (Boyce & Xing, 2008). Parathyroid hormone (PTH) stimulates
the production of RANKL while suppressing the effect of OPG, leading to increased
osteoclast activity. In contrast, estrogen can increase the expression of OPG, and inhibit
RANKL signals (Clarke, 2008).
After age 30, a normal skeleton experiences gradual loss in BMD, characterized
by a decrease in the activity of osteoblasts compared to osteoclasts (Clarke, 2008). Many
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factors can accelerate or hinder this loss, including medication, proper nutrition, and
physical activity. Osteocytes can sense increased workload in bone, changing the
differentiation of osteoblasts to increase BMD. When bone experiences decreased
loading, resorption occurs to eliminate the underutilized bone, leading to potential
fragility fractures.

Figure 2.1: Normal and Osteoporotic
Bone Remodeling and Biochemical
Markers (Srivastava et al., 2005)
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Osteoporotic Bone Mechanisms/Pathologic Response
Age-related bone loss is a natural occurrence, modulated primarily by the rapid
decline in sex hormones. While the rate of bone mass lost varies on an individual basis,
the postmenopausal osteoporotic period is marked by a more rapid rate of bone loss in
women, as noted in Figure 2.1. After this period, the rate of loss returns to a more gradual
decline (Mazess, 1987). Low, as well as high, bone turnover rates, with bone resorption
greater than bone formation, lead to the accumulation of microfracture and
microarchitectural deterioration respectively (Clarke, 2008).
Menopause is thought to be due to decreased ovarian function, leading to reduced
estrogen secretion by 85-90% when compared to premenopausal levels (Khosla,
Atkinson, Melton, & Riggs, 1997). The assessment of bone resorption and bone
formation markers in postmenopausal women suggests a rise by roughly 90% and 45%,
respectively (Garnero, Sornay-Rendu, Chapuy, & Delmas, 1996). This imbalance
primarily favors bone resorption, leading to accelerated post-menopause bone loss
(Clarke & Khosla, 2010). The cellular mechanisms by which estrogen withdrawal leads
to bone loss are regulated in part by osteoclast development and apoptosis. It is believed
that estrogen withdrawal increases the signaling processes of RANKL, when compared to
pre-menopausal levels, in turn increasing osteoclast recruitment, and decreasing the rate
of osteoclast apoptosis (Clarke & Khosla, 2010). The pathophysiology of this disease
alters the normal physiology of bone turnover by decreasing the expression of OPG, and
increasing the RANKL/RANK signaling process, thereby increasing rate of resorption
over formation.
In addition, postmenopausal bone loss is secondarily due to a decrease in bone
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formation rates when compared with premenopausal levels. Because estrogen directly
stimulates bone formation, absence of estrogen may lead to impaired bone formation or
increased bone loss (Heaney, Recker, & Saville, 1978). Previous literature has thoroughly
explored this causal relationship, providing thorough verification that estrogen can
stimulate bone formation after the skeleton has reached peak bone mass (Khastgir et al.,
2001; Tobias & Compston, 1999), although not to a level to overcome resorption.

Assessment and Diagnosis of Osteoporosis
It has been demonstrated that osteoporosis primarily affects postmenopausal
women (Yamazaki, Ichimura, Iwamoto, Takeda, & Toyama, 2004), however one in four
men over the age of 50 is diagnosed as well. There are several additional risk factors that
cause someone to be more susceptible or prone to osteoporosis. These include but are not
limited to: age (≥ 50), smoking, low body weight, genetics, physical inactivity, alcohol
consumption (≥ 3 drinks per day), low dietary calcium intake, vitamin D deficiency, and
or long term use of seizure medication and steroids (Sugerman, 2014).
The primary diagnostic assessment for osteoporosis centers on measuring BMD
because the disease is, in part, defined by low bone mass and increased bone fragility.
Most often, BMD is quantified through the use of dual energy x-ray absorptiometry
(DXA), which scans the central or axial skeleton (spine and hip). Advantages to DXA
include short scan times, high precision, and stable calibration techniques. The low dose
radiation (Njeh, Fuerst, Hans, Blake, & Genant, 1999) poses no threat larger than the
average daily dose from everyday background radiation (Blake & Fogelman, 2002).
While the spine provides more metabolically active tissue for better monitoring of
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treatment responses, measurement of hip BMD has been shown to provide reliable and
predictive indications of fracture risk (Blake & Fogelman, 2002).
When compared with alternative methods that measure bone densitometry, central
DXA scans provide results that can be interpreted using the World Health Organization
(WHO) T-score classifications of osteoporosis (Kanis & Gluer, 2000b; World Health
Organization, 1994). As illustrated in Figure 2.2, diagnostics for osteoporosis in
postmenopausal women is often defined by the reference values for Caucasian women:
BMD ≤ -2.5 standard deviations (SD) from the average value for premenopausal women
(Blake & Fogelman, 2007). This is represented by a T-score, which evaluates the
participant’s BMD compared to the young and healthy adult reference group.

Figure 2.2: Diagnostic Criteria for Osteoporotic Women
Based on the Distribution of BMD in a Young, Healthy
Adult Population (Kanis & Gluer 2000)
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Persons who have experienced marked bone loss, such as postmenopausal
women, have a tendency to exhibit a negative T-score because they have less BMD when
compared with the standard. A T-score between -1 to 1 suggests normal, healthy bones; 1 to -2.5 means the person has osteopenia, or low bone density; ≤ -2.5 offers a diagnosis
of osteoporosis (Kanis & Gluer, 2000b).
While normal reference ranges exist for many countries (Arlot, Sornay‐Rendu,
Garnero, Vey‐Marty, & Delmas, 1997; Lehmann et al., 1995; Looker et al., 1998; Lunt et
al., 1997; Ryan, Spector, Blake, Doyle, & Fogelman, 1993; Shipman et al., 1999; SmeetsGoevaers et al., 1998), the difference in mean BMD, as well as the standard deviation, is
minimal, suggesting the use of population specific reference ranges to be unnecessary.
Variations in fracture risk appear to be substantially higher than variations in BMD
across populations (Kanis & Gluer, 2000a), suggesting BMD and fracture risk are not
directly proportional. For example, in Asia, the risk of hip fracture is lower than in
Northern Europe or the USA, but BMD is also lower (Looker et al., 1998; Melton, 1997).

An Alternative Measure: Biochemical Markers of Metabolism
Although BMD has proven useful for clinical diagnosis of osteoporosis, changes
in bone mass occur slowly, causing static measurement of BMD, such as DXA, to be an
inadequate measure of dynamic changes occurring as a result of prevention and treatment
strategies. While DXA is mainly utilized in long term studies to set baseline and final
BMD data, biochemical markers can be used during short-term (<6 months) and long
term research to monitor therapies during intervention or treatment to assess progress.
For example, exercise elicits a skeletal response, measurable by analyzing urine and
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blood serum biomarkers to estimate the rate of bone remodeling (Franck, Beuker, &
Gurk, 1991). Biomarkers of bone metabolism can also be used to predict the rate of bone
degradation and formation in postmenopausal women, and assess risk factors for fracture
(Eastell & Hannon, 2008).
The efficacy of biomarkers in assessing the rate of reduction in fracture risk has
been illustrated in many clinical trials (Bonnick & Shulman, 2006; Cummings et al.,
2002; Hochberg et al., 2002; Wasnich & Miller, 2000), resulting in the suggestion that
biomarkers may be able to note changes in risk factors before any modifications in BMD
become evident. In studies conducted by Bonnick and Schulman (2006) investigating the
effects of monitoring biomarker response to antiresorptive therapies as a treatment for
osteoporosis, the researchers discovered that benefits to the spine have been observed
even among women who maintain rather than increase BMD during therapy. During
these trials, the authors showed that suppression of bone remodeling markers could occur
after as few as 3 months after the onset of therapy, and that this suppression is highly
associated with decreased risk for fracture. These results suggest that biochemical
markers may provide valuable data for assessing the progress of therapeutic agents,
particularly during treatment or before fluctuations of BMD can be distinguished.

Biochemical Markers for Bone Formation. Significant developments in cell
biology, metabolism, and pathology have led to advancements of assays for testing
biochemical markers, making them more sensitive and marker-specific. Biochemical
markers are classified according to the process by which products of osteoblasts and
osteoclasts are created. Bone formation markers are the result of osteoblast activity,
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expressed during different stages of bone cell development, and reflect phases of bone
formation. All bone formation markers are measured in blood serum or plasma (Delmas
et al., 2000).
Osteoid forms during the early phases of bone formation, and is made up of
nearly 90% type 1 collagen (Naylor & Eastell, 2012). Type 1 collagen, the most abundant
form of collagen in bone, is expressed by osteoblasts, and requires the splitting off of the
carboxy (C-) terminal (P1CP) and amino (N-) terminal (P1NP) of the propeptides of type
1 collagen (Melkko et al., 1996; Melkko, Niemi, Risteli, & Risteli, 1990), as seen in
Figure 2.3.

Figure 2.3: Extracellular Events in the
Synthesis of Collagen Fibril (Kadler, Holmes,
Trotter, & Chapman, 1996).
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While type 1 collagen has been previously considered to turnover at a relatively
low rate, recent studies have indicated that peritendinous connective tissue responds at a
higher rate to metabolic and inflammatory activity than previously shown (Langberg,
Skovgaard, Karamouzis, Bulow, & Kjaer, 1999). These markers are then released into
circulation, signifying bone collagen synthesis (Langberg, Skovgaard, Petersen, Bulow,
& Kjaer, 1999). Although Type 1 collagen is not specific to bone tissue, and is also
produced by the skin and tendon, circulating levels of these markers are mainly derived
from bone metabolism. Furthermore, most non-skeletal tissues experience a much slower
rate of turnover when compared to bone, contributing minute amounts to the circulating
pool of P1NP (Vasikaran, Eastell, et al., 2011).
Several studies have shown positive correlation between the rate of bone
formation and serum P1CP levels (Adami, Bianchi, et al., 2008; Horowitz, 2010). In
order to standardize the future biochemical bone turnover research, the International
Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry
(IFCC) suggest the use of P1NP as the marker of bone formation to be used for reference
analyses (Naylor & Eastell, 2012; Vasikaran, Eastell, et al., 2011) due to its greater
diagnostic validity.

Biochemical Markers for Bone Resorption. Most biochemical markers of bone
resorption are products of bone collagen degradation (Pagani, Francucci, & Moro, 2005).
When type I collagen is degraded by osteoclasts, and amino- (NTX) and carboxy- (CTX)
terminal telopeptides of type 1 collagen are released into circulation, increasing the
concentration in the blood stream during the resorption process. Current literature
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suggests that, although the mechanism by which exercise positively effects bone turnover
in postmenopausal women remains poorly understood, bone resorption markers,
specifically serum CTX, were the most significant indicators for estimating the effects of
intervention methods in early postmenopausal women (Chailurkit, Ongphiphadhanakul,
Piaseu, Saetung, & Rajatanavin, 2001). Furthermore, the authors suggested CTX to be
the most significant predictor of long-term BMD change following therapeutic
intervention, when compared to other clinical markers of both formation and resorption.
Results from studies attempting to model osteoporotic conditions by utilizing
ovariectomized rats, have supported this model, indicating that exercise can inhibit bone
resorption, leading to further reduction of bone loss (Li et al., 2014). An increase in BMD
through the suppression of bone resorption in response to short-term duration exercise
has been reported previously in young growing rats as well (Hagihara et al., 2009).
Therefore, the International Osteoporosis Foundation (IOF) has recommended that the
serum CTX be used as the reference marker for bone resorption because of the adequate
characterization of the marker, specificity to bone, and performance in previous clinical
studies (Vasikaran, Cooper, et al., 2011; Vasikaran, Eastell, et al., 2011).
Blood serum markers of bone turnover have been established as good measures of
progress during therapy interventions, and their direct correlation to the eventual
calcification and mineralization, suggesting an increased BMD, has been extensively
researched (Lester et al., 2009). Any inconsistency has been suggested to be due to the
difficulty in predicting the mode, volume, and intensity needed to maximize the
osteogenic response. Several studies have investigated both the appropriate age-specific
reference intervals from global and national representative populations, as well as the
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relationship between bone turnover markers and BMD in postmenopausal women (Hu et
al., 2013; Jenkins et al., 2013). After examining 2799 individuals aged 20-79 years in
Shanhai, China, Hu, Z. Zhang, He, Fu, Wang, H. Zhang, Yue, Gu, and Z. L. Zhang
(2013) established normal reference ranges for bone turnover markers (OC and CTX).
They found these bone turnover markers correlated with BMD. In a subsequent study on
Australian reference populations, data obtained from a large study offered reference
intervals for amino-terminal of propeptides of type 1 collagen and CTX biomarkers in
serum. Further research studying pharmacological treatments for osteoporosis, such as
with Alendronate, Risedronate, and Raloxifene on bone turnover markers show a strong
correlation with decreased fracture risk than BMD (Eastell & Hannon, 2008). These
findings suggest bone biomarkers rather than BMD should be monitored throughout
interventions. Therefore, the use of biochemical markers of bone turnover may be a more
effective skeletal health assessment during short-term observations of treatment
interventions than pure densitometry.

Treatment Interventions
Pharmacological
Osteoporosis is not an inevitable disease and its progress can be slowed through
several treatment modalities. According to the US Surgeon General, osteoporosis
responds to treatment (Office of the Surgeon General, 2004). The US Food and Drug
Administration (FDA) has approved two classes of pharmaceutical treatments, anabolic
and antiresorptive agents, in the treatment of osteoporosis. While anabolic medications,
such as Teriparatide (Fortical), help lower the risk of fracture by stimulating new bone
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formation and increasing BMD through increased bone modeling (Lindsay et al., 2006;
Stepan et al., 2003), antiresorptive agents (bisphosphonates, Denosumab, Raloxifene,
hormone therapy/estrogen therapy, and calcitonin) focus on strengthening the existing
skeleton, and preventing bone loss through ensuring adequate remodeling (Canalis,
Giustina, & Bilezikian, 2007; Meunier, 2001). Pharmacological agents have been shown
effective, albeit concerns associated with potentially detrimental side effects on other
body tissues leads many to non-adherence (McHorney, Schousboe, Cline, & Weiss,
2007) as seen in Table 2.1 (Cosman et al., 2014). Because of the side effects associated
with pharmacological therapies, physical activity has been recommended as a potential
alternative, as well as an adjunct to other prevention and treatment strategies (Berard,
Bravo, & Gauthier, 1997; Kelley, 1998)
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Table 2.1. Side Effects of Fracture-Prevention Medication (Adapted from Cosman et al. (2014))
Medication
Classification Side Effects
Bisphosphonates
Antiresorptive  Diarrhea, nausea, vomiting, heartburn, esophageal
irritation, gastric ulcer
 Low calcium levels in the blood
 Potential for increased risk of femur fracture if continued
for > 5 years
 Bone, joint, muscle pain
 Permanent bone deterioration of the jaw
 Visual disturbances
Calcitonin

Antiresorptive



Estrogen/Hormone
Replacement Therapy
(ERT/HRT)

Antiresorptive

ERT:
 Increased risk of developing endometrial cancer
 Breast swelling or discomfort, Breast cancer
 Bilateral swelling of the legs or feet; rapid weight gain
 Heart disease, blood clots
 Stroke

Estrogen Agonist/antagonist
(SERMs)
Human Parathyroid
Hormone (PTH);
Teriparatide

Antiresorptive
Anabolic

Other Notable Information
 Patients should follow label
instructions exactly to
decrease risk of esophageal
side effects

Rhinitis, Epistaxis, Nose bleeds

HRT:
 Chest pain, unexpected coughing, difficulty breathing
 Dizziness, change or loss of vision, fatigue
 Stroke, heart disease
 Raloxifene may increase the risk of deep vein thrombosis
o
Increases hot flashes
 Leg cramps, dizziness
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In studies of
postmenopausal women
who were diagnosed with
osteoporosis, estrogen did
not reduce the risk of
fractures



Given the serious side
effects, it is generally not
used solely to treat
osteoporosis



Not to be used for more
than 2 years

Physical Activity
The Surgeon General asserts that physical activity and proper nutrition should be
the initial intervention methods for osteoporosis, prior to any pharmacological treatment
(Office of the Surgeon General, 2004). While pharmaceutical intervention can increase
bone mass, physical activity has the potential to both increase bone mass and improve
bone strength. Additionally, physical activity can delay the deterioration of age related
bone loss in older populations (Berard et al., 1997; Marcus, 1998; Umemura, Sogo, &
Honda, 2002). Physical exercise decreases risk factors for falling (Liu-Ambrose, Eng,
Khan, Carter, & McKay, 2003) and improves balance (Chien, Wu, Hsu, Yang, & Lai,
2000; Jessup, Horne, Vishen, & Wheeler, 2003; Madureira et al., 2007), making it an
important primary prevention strategy. Law, Wald, and Meade (1991) evaluated the
relationship between hip fracture occurrence and osteoporosis treatment modalities in a
review of epidemiological studies, concluding that that physical activity was the most
impactful measure in preventing hip fracture.
With respect to the mechanisms underlying the beneficial impact of physical
activity on bone health, the mechanical loading provided by physical activity acts as a
stress stimulus, producing physiological adaptations that, over time, lead to a variety of
health benefits, including stronger bones, increased physical fitness, and cardiovascular
health (Kemmler et al., 2004; Roghani et al., 2013). As previously illustrated by Wolff’s
law, physical activity increases the mechanical load placed on the skeleton, in an attempt
to modify bone structure. These internal and external forces must be greater than
normally exhibited by activities of daily living to stimulate the osteogenic response for
bone formation (Lanyon, 1984; Umemura et al., 2002) Exercise’s osteogenic effect
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occurs slowly and is site-specific (Adami, Gatti, et al., 2008); BMD only increases at the
anatomic sites where the mechanical strain occurs (Haapasalo et al., 1994; Lanyon, 1996;
Tommerup, Raab, Crenshaw, & Smith, 1993). Despite our mechanistic understanding of
the influence of exercise on BMD, findings have been conflicting regarding the impact of
exercise interventions on BMD. Inconsistencies may be attributed to variations in the
type, duration, frequency, and intensity of the exercise interventions tested (Gutin &
Kasper, 1992; Rutherford, 1997; Stewart et al., 2005).

Effects of High Intensity Impact Training on Bone Density and Metabolism.
Currently, the American College of Sports Medicine (ACSM) recommends a variety of
exercise modes and intensities to effectively maintain bone mass in postmenopausal
women (Kohrt, Bloomfield, Little, Nelson, & Yingling, 2004). Traditionally, high impact
and weight bearing activity has been shown to produce a greater osteogenic response
(Yamazaki et al., 2004; Zehnacker & Bemis-Dougherty, 2007), but such high-impact
programs may be associated with increased fracture risk and injury in postmenopausal
osteoporotic women (Martyn-St James & Carroll, 2006; Roghani et al., 2013).
In a one year randomized, controlled trial investigating the effect of high-intensity
resistance training on postmenopausal women, Nelson, Fiatarone, Morganti, Trice,
Greenberg, and Evans (1994) found that women who participated in resistance training
program 2 days per week increased their BMD by 1% at the hip and lumbar spine. The
control group lost 2.5% and 1.8% at the hip and spine respectively. Furthermore, a study
by Kerr, Morton, Dick, and Prince (1996) reported similar results, suggesting
participating in a high intensity, low volume strength-training regimen can increase BMD
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more than a high volume, low intensity program.
A meta-analysis of high intensity resistance training and bone loss in
postmenopausal women found that regular exercise at this level helps maintain BMD in
the lumbar spine (Martyn-St James & Carroll, 2006). While resistance training protects
BMD in the spine, it seems additional physical activity modalities are necessary to elicit
such improvements in the femoral neck of the hip. Kemmler and Engelke (2004) note
that while the high impact exercise promotes a higher osteogenic response and increased
bone formation, it may cause unfavorable effects on persons with osteoarthritis and/or
lower back pain. The conclusions of the meta-analysis and related research suggest that
high intensity resulting in overloading the skeleton is more important than the number of
repetitions for increasing BMD in postmenopausal women, but that caution should be
taken in prescribing these activities.
Although previous studies have used a wide variety of exercise prescriptions,
current literature is in agreement that weight-bearing exercises involving gravitational
stimulation, such as gymnastics, running, jumping activity, institute an escalation in
BMD when compared to physical activity not directly affected by gravity, such as
swimming (Creighton, Morgan, Boardley, & Brolinson, 2001). Based on this research, a
combined resistance training and weight bearing exercise program is recommended to
older individuals attempting to increase or maintain their both bone density and strength
to ensure safety to the individual.
While increased physical activity and exercise promote bone formation, a decline
in physical activity decreases musculoskeletal loading and is associated with muscular
atrophy and decreased strength, balance, and coordination, all of which increase risk for
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fracture (Roghani et al., 2013). Decreased muscle mass results in a loss of muscular
tension, removing a degree of muscle contraction necessary for musculoskeletal health
(Bogdanis, 2012). While several studies have thoroughly investigated the osteopenic
effects of weightlessness in astronauts (Birge & Whedon, 1968), the effects of inactivity
in postmenopausal osteoporotic women has only been minimally addressed (Krolner &
Pors Nielsen, 1982; Krolner, Toft, Pors Nielsen, & Tondevold, 1983).

Effects of Aerobic Exercise on Bone Density and Metabolism. The ability to use
aerobic exercise to evaluate bone turnover rates has previously been explored utilizing a
variety of populations and methodologies due to its potential as an alternative to
pharmacological interventions. There is a large body of research investigating the
difference between bone density measures of various athletic groups and matched
sedentary controls. In general, results show difference (6-20%) in BMD and BMC
between exercisers and controls at different anatomical sites, over a wide range of
physical activities (Rutherford, 1997). The type of activity can affect the degree of
increase in BMD. Nilsson and associates compared the BMC of 24 male weight lifters
and 21 professional ballet dancers (men and women) with age-matched healthy controls
(Nilsson et al., 1978). The results indicated that BMC was higher in both dancers and
weightlifters. Increased bone width was found predominantly in the dancers even though
they were shorter and weighed less than the controls. This data suggests that, when
controlling for nutrition, physical activity started early in life results in high BMC and
increased bone dimensions.
Nilsson & Westlin (1971) measured bone density in the distal femur in a variety
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of male athletic groups ranked by the load taken on the lower limb (weight-lifters,
throwers, runners, soccer players, swimmers and controls). In this study, bone density
was ranked in the same order, with no difference between the swimmers and the controls.
Similar results have been seen in female athletic groups, showing that women regularly
participating in sports associated with high impact loading, such as volleyball and
gymnastics, have greater bone densities in the spine, femoral neck, and legs compared to
swimmers and controls (Fehling, Alekel, Clasey, Rector, & Stillman, 1995). Additional
cross-sectional studies of young adults show greater bone mass in athletes than in age and
sex matched non-exercising controls (Block et al., 1986; Talmage et al., 1986). Even
competitive runners in their sixth decade and beyond have been reported to demonstrate
40% higher BMD than non-exercising controls (N. E. Lane et al., 1986).
A second study assessed the osteogenic effect and changes in bone markers in
healthy subjects by 12 weeks of aerobic training (Alghadir et al., 2014). Sixty-five
healthy subjects, ages 30-60 years participated in this study. Twelve weeks of moderate
aerobic training, 3 times per week, produced significant improvements in all bone
metabolism indices among subjects. The authors measured bone formation markers
(osteocalcin (OC), and bone specific alkaline Phosphatase (BAP)) and the bone
resorption marker Deoxypyridinoline (DPD), and serum calcium. Alghadir and
colleagues (2014) concluded that moderate intensity aerobic exercise could exert
significant positive effects on bone formation markers and bone density, while also
significantly decreasing the rate of bone resorption. In this study, bone formation markers
(OC, BAP) showed a significant increase in all subjects, while bone resorption markers
(DPD) were significantly lower than when taken at baseline. These observations suggest
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that moderate aerobic exercise increased the rate of bone remodeling. The authors
concluded that long term aerobic exercise could be associated with decelerated bone
resorption and normal to elevated bone formation.
With respect to the impact of aerobic exercise training on the bone health of older
adults, Blumenthal, Emery, Madden, George, Coleman, Riddle, McKee, Reasoner, and
Williams (1989) evaluated the physiological adaptations to 4-months of aerobic exercise
training on 101 older men and women. Subjects were randomly assigned to one of three
groups: aerobic exercise, yoga and flexibility, or waitlist control. Prior to and after 4months of intervention, participants underwent physiological and psychological
evaluations, including but not limited to bone density measurements. Measurement of
BMD was by single photon absorptiometry with I-125 was performed using a bone
densitometer (Norland Corporation, Fort Atkinson, WI). BMC (mg/cm2) was taken from
the distal radius of the non-dominant arm. The authors discovered an increase in BMC
for subjects at risk for bone fracture, suggesting that 4-months of aerobic exercise may
increase BMC in individuals with low bone density and who are at risk for fracture. The
authors concluded that, although the mechanism remains unclear, the results suggest
exercise may increase bone density.
In response to recommendations for evaluating biomarkers over a longer duration,
Yamazaki, Ichimura, Iwamoto, Takeda, and Toyama (2004) examined whether moderate
walking exercise in postmenopausal women with osteoporosis would affect bone
metabolism over the course of a year. Fifty postmenopausal women were assigned to
either the exercise or control groups. The exercise consisted of 4 days per week of 1 hour
per day of outdoor walking at 50% maximal oxygen consumption. Participants were
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required to complete 8,000 or more steps during this time. Lumber BMD was measured
using DXA in both groups. Serum bone-specific alkaline phosphatase (BAP) and urinary
cross-linked amino-terminal telopeptides of type 1 collagen (NTX) levels were measured
at baseline, 1, 3, 6, 9, and 12 months by enzyme-linked immunoassay (EIA) and enzymelinked immunosorbent assay (ELISA) respectively. Findings from this study support
those of previous research, in that the mechanism for the positive response of lumbar
BMD to moderate walking appears to be the suppression of bone turnover.
A study by Thorsen, Kristoffersson, and Lorentzon (1996) explored the effects of
a single bout of brisk walking on bone and calcium metabolism markers in
postmenopausal women. Twelve subjects participated in a single bout of brisk walking at
50% VO2max for 90 minutes. Calciotropic hormones, markers of type I collagen
formation (P1CP) and degradation (ICTP), and the amino terminal propeptide of type III
collagen in serum (PIIINP) were measured at baseline, 1-hour, 24-hours, and 72-hours
post exercise. Total body BMD and BMC were measured by DXA. A significant increase
in P1CP was observed at 24- and 72-hours (P<0.01) after exercise, and there was a
significant decrease in ICTP at one hour (P<0.05), followed by an increase at 72 hours
(P<0.001). A significant increase from rest was also seen in PIIINP at 24 and 72 hours
(P<0.05) post exercise. Results indicated a lack of correlation between P1CP and ICTP,
suggesting an uncoupling between the bone resorption and formation processes. This
uncoupling is consistent with the mechanism of bone loss during menopause, and further
escalated by the onset of osteoporosis. Although no significant difference was found
between P1CP and ICTP at 72 hours, the results of this study suggest that one bout of
brisk walking altered bone collagen turnover. The author’s findings suggest that an acute
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bout of exercise exhibits a change in biochemical bone turnover markers that may
stimulate a cascade of response that continue once threshold stimulus levels are reached.
The lack of significant change in levels of calciotrophic hormones was explained by
inadequate exercise intensity, but contradicted by the altered concentrations of serum
P1CP and ICTP (Thorsen et al., 1996). In order to increase exercise intensity, the addition
of gravitational forces acting on the body via weighted load carriage, or increasing the
rate of work would be necessary.
In sum, previous research has shown that when compared with their nonexercising control counterparts, individuals who exercise, whether it be young athletes or
older individuals, increase their BMD and have a better chance of maintaining that BMD
as they age. Despite this knowledge, the effects of aerobic exercise on bone metabolism
are not well established or consistent, with some studies showing beneficial results for
women with osteoporosis (Alghadir et al., 2014; Yamazaki et al., 2004), while others are
uncertain (Blumenthal et al., 1989; Thorsen et al., 1996). The increased risk of fracture
associated with postmenopausal osteoporotic women (Arlot et al., 1997; Cauley, 2013;
Clarke & Khosla, 2010) necessitates more studies to develop safe, prescribable exercise
interventions that provide an adequate osteogenic response on the skeletal system.

Load Carriage Systems During Exercise on Bone Density and Metabolism. It has
been proposed that the osteogenic response to aerobic exercise could be improved by
adding additional external weight-bearing force via load carriage systems (LCS) to
physical activity interventions. By utilizing LCS such as backpacks, weighted vests,
ankle weights, etc., the load on the skeleton can be increased without increasing risk for
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injury (Burr, Martin, & Martin, 1983; Kai, Anderson, & Lau, 2003). Shaw and Witzke
(1998) postulated that forces greater than those experienced by activities of daily living
must impact bone mass to achieve the appropriate level of overload to activate the
osteogenic response, suggesting that by externally increasing the forces acting upon the
body, the osteogenic response could also be increased.
Research supports the positive relationship between increased vertical ground
reaction forces via carrying additional load and the effects on skeletal bone formation
(Kai et al., 2003), and osteogenesis. One study investigated the different effects of
loading and unloading conditions on bone-on-bone forces in 7 healthy male participants
(Simonsen et al., 1995). Results showed that 20kg loaded walking generated an
additional 8.0% body weight compression force at the hip joint. Additional studies by
Kinoshita (1985), Knapik (1996), Hsiang and Chang (2002) evaluated the relationship of
loaded walking ground reaction forces with the completion of gait patterns when
compared to the same unloaded conditions. Their results concluded that the amount of
loading, if too heavy, produced negative effects on gait patterns, while moderate loads
improve gait stability.
In a subsequent study on postmenopausal women with osteoporosis, Snow, Shaw,
Winters, and Witzke (2000), found that participating in 9-months of exercise wearing a
weighted vest (10-20% BW), showed significant improvements in indices of fall risks,
lower body muscular strength, and muscular power, when compared to the nonexercising control group. However, they found no significant change in hip BMD, likely
due to the lack of exposure to sufficient stimulus over the short duration of the study.
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While current research has thoroughly explored the effects of LCS on vertical
ground reaction forces and their impact on bone density and metabolism, less attention
has been paid to the proper distribution of load on the body. The most effective and safe
method of load distribution is to keep the load as close to the body’s center of mass
(COM), while allowing the larger muscle groups to move the load (Legg & Mahanty,
1985). This configuration allows the body to work more efficiently against the added
load, while maintaining proper upright posture (Harman, Frykman, Knapik, & Han, 1994;
Kinoshita, 1985). Weighted vests, which load the upper body, have been shown to
produce balance improvements in postmenopausal women with osteoporosis (Roghani et
al., 2013; J. M. Shaw & Snow, 1998). However, poorly designed weight layout can lead
to feelings of imbalance (Birrell & Haslam, 2010), and back or shoulder pain. Further
research into the design of LCS, recommends spreading the load around the trunk,
focusing on both anterior and posterior load to increase economy and maintain normal
gait patterns (Lloyd & Cooke, 2011).
In summary, current literature suggests that increasing vertical ground reaction
forces by utilization of LCS during walking activity may provide osteogenic stimuli by
producing higher impact forces in the lower limbs. These increases further support the
suggestion for physical activity while wearing properly designed LCS in the treatment of
osteoporosis (Watanabe, Asaka, & Wang, 2012).

Influence of Aerobic Exercise with LCS on Bone Density and Metabolism.
Externally loaded exercise has been shown to increase or maintain bone mass in younger
and older populations, but the mechanisms by which mechanical loading stimulates bone
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metabolism are not well known. Current literature examining the effects of externally
loaded aerobic exercise on bone turnover serum has produced conflicting results
(Greendale, Hirsch, & Hahn, 1993; Roghani et al., 2013; Tosun et al., 2006). To our
knowledge, there have only been two studies investigating the effect of external load
training during aerobic exercise on bone turnover biomarkers. A third study was found,
utilizing DXA rather than biochemical markers.
One study, by Tosun, Bolukbasi, Cingi, Beyazova, and Unlu (2006), investigated
the acute effects of brisk walking, with and without weight lifting, on bone turnover in
healthy young women. The aim was to determine if external loading elicited a greater
osteogenic response. Unlike previous studies, nine women performed both exercise
bouts: brisk walking on a treadmill for 30 minutes, and an identical exercise but while
carrying 5kg of weight in a backpack. Intensity of submaximal aerobic exercise was
determined by 60-85% HRmax. The investigators measured and studied serum parathyroid
hormone (PTH), osteocalcin (OC), calcitonin (CT), carboxy-terminal propeptide of type
1 collagen (P1CP), amino-terminal propeptide of type 1 collagen (P1NP), type 1 collagen
carboxy terminal telopeptide (ICTP), total alkaline phosphatase (ALP) and urine
Deoxypyridinoline (DPD) at baseline, 30 min, 45 min, and 1 hour post exercise. Testing
produced statistically significant variance only in serum ALP and PTH values. ALP was
found to be significantly decreased 24 hours after aerobic exercise, but significantly
increased 24 hours post weighted aerobic exercise. Alkaline phosphatase is a bone
formation marker, suggesting that the addition of external loading to brisk walking
produced anabolic effects on bone metabolism. The decrease post non-weighted aerobic
exercise suggests a decrease in bone formation (Tosun et al., 2006). It was concluded that
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brisk walking for 30 minutes had a stimulating effect on bone metabolism, without any
significant effects of adding weight. The authors noted that their results are specific to
healthy young women, and cannot be generalized to postmenopausal osteoporotic women
due to the estrogen receptor response protecting against resorption (RANKL/RANK/OPG
relationship). Thus, further studies aimed at postmenopausal osteoporotic women should
be performed to evaluate the effects of external loading on bone metabolism.
A second study investigated the effect of aerobic exercise intervention using a
weighted vest on perceived health status and BMD in older persons (Greendale et al.,
1993). In this study, 36 seniors were recruited and randomly assigned to one of two
groups: vest-use or discussion control. Both groups met for 1 hour per week for 20
weeks; the vest group wore a weighted vest while participating in a low-level exercise
class and the discussion group met and reviewed topics relevant to aging, such as
choosing a doctor, health insurance, or pharmacological interventions. The beginning
weight load of the vest was 0.45 kg, increasing over the duration of the study to a total of
3.6 kg maximum. At baseline and 20 weeks, participants completed a health status
questionnaire and bone density was measured by DXA. The authors found that bone
density was similar in both groups at baseline (1.037 g/cm2 and 1.016 g/cm2 respectively,
p = 0.75). At 20 weeks, the discussion group presented a -0.59% (-0.0068 g/cm2)
decrease in BMD, while the weighted vest groups BMD increased by 1.02% (0.0101
g/cm2) from baseline. Despite these promising results, the authors found no statistically
significant difference between groups. The authors concluded that the use of a weighted
vest provided gains in quality of life in elderly, but suggested using the weighted vest, as
an osteogenic stimulus intervention, deserves further research.
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A subsequent study looked at the effect of short-term aerobic exercise with and
without external loading on bone metabolism, found that after a 6-week exercise
program, BALP increased and NTX decreased significantly in both exercise groups
(Roghani et al., 2013). In this study, 36 sedentary, postmenopausal women with
osteoporosis were randomly split into three groups: aerobic, weighted vest, and control.
The exercise intervention for the aerobic exercise group consisted of 18 sessions of
submaximal walking on a treadmill for 30 minutes per day, 3 times per week. The
exercise intervention for the weighted vest group was identical to the aerobic exercise
group, except for the addition of wearing the weighted vest (4-8% of body weight). The
authors concluded that simply walking on a treadmill, with or without the weighted vest,
creates a satisfactory osteogenic stimulus, generated from both the participants’ body
weight and muscular contraction. The weighted vest additionally loads the pelvic and
lumbar spine, stimulating further muscular when contractions compared to the same
walking exercise without additional weight. Further results from this study suggest that
submaximal walking, while wearing additional weight, helps maintains the homeostatic
balance of bone turnover in osteoporotic postmenopausal women (Roghani et al., 2013).
While the previous studies all found that exercise positively stimulated bone
turnover or maintenance of BMD, they could not differentiate significantly between
aerobic exercise and weighted aerobic exercise groupings. Across all 3 studies, the
authors noted that the lack of significant findings was most likely to do their study
limitations. Tosun et al., (2006) tested a healthy young female population, whose bone
metabolism is protected by the estrogen complex; Greendale et al., (1993) assessed both
male and female older adults, and suggested their study was limited to the weight of the
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vest and duration of the exercise bout; Roghani et al., (2013) focused solely on
postmenopausal women with osteoporosis, again picking a low vest weight, and short
exercise bout duration. Research conducted by Snow et al., (2000) suggests a weight of
10-20% body weight is acceptable to be utilized during exercise interventions with
postmenopausal osteoporotic women, with the recommendation that increasing from 10%
to 20% should be done conservatively and over time. A secondary cause of lack of
differentiation may be due to the intensity of exercise overpowering the low weight used
during exercise.
While limitations of previous LCS designs have provided a substantial lack of
evidentiary support, new developments in wearable technology, such as the uniformly
weighted exercise suit, show promise in providing adequate weight bearing stimulus
during exercise in a well-designed and safe manner (Curry et al., 2015). The design of the
suit mimics the natural weight distribution of the human body, with the jacket slightly
heavier than the pants, so as to not significantly alter the wearer’s center of gravity.
Furthermore, the whole body loading design allows for the increased forces to be more
evenly distributed across all major muscle groups instead of simply the upper or lower
body, allowing for a decrease in the likelihood of injury such as back, shoulder, or hip
pain (Knapik et al., 1996).

In review, the available literature suggests:


While BMD is the gold standard for evaluating long-term treatment, biochemical
markers of bone turnover are a good measure of progress during treatment
interventions.
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The short-term increase in bone formation markers is correlated to long-term BMD
change if the treatment is continued.



Physical activity is a sufficient stimulus to produce increases in bone formation
markers.



Aerobic exercise may provide a safer alternative to high intensity impact training in
postmenopausal women with low bone density or osteoporosis.



Externally loaded aerobic exercise, through the use of a well-designed LCS, can
increase the forces acting on the body, increasing bone formation markers.



Research is needed to assess whether uniformly weighted LCS (e.g., an exercise suit)
can overcome the limitations of existing LCS and have positive effects on bone
formation and resorption biomarkers suggested by the IOF and IFCC.

Conclusions
Although research shows pharmacological treatments are effective in increasing
and maintaining BMD in postmenopausal women with osteoporosis, they are associated
with potentially detrimental side effects. The non-adherence to such interventions has
spurred the investigation into alternative treatment options, such as physical activity. The
osteogenic effect of exercise provides a stimulus for bone formation, which can be
monitored throughout treatment through the use of biochemical markers of bone
turnover. While several studies have shown high intensity, high impact training to
stimulate a greater osteogenic response, aerobic exercise has been deemed a sufficient
and safer alternative, albeit not as good. To improve the effects of aerobic exercise,
research has begun to investigate the effects of externally loading the body through the
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use of LCS. While there is evidence that aerobic exercise while wearing LCS positively
affects bone formation and resorption serum markers, insignificant research results are, in
part, due to the utilization of weight loads well below the recommended values that can
be used safely in this population. If heavier, well-distributed LCS can increase
biochemical markers of bone formation while decreasing markers of bone resorption,
they have long-term positive effects on increasing and maintaining BMD.
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Chapter III
METHODS

Overview and Design
The purpose of this study was to examine the effects of a uniformly weighted
exercise suit on biochemical markers of bone formation (carboxy [C-] terminal [P1CP]
and amino [N-] terminal [P1NP] of the propeptides) and resorption (carboxy- [CTX]
terminal telopeptides of type 1 collagen) in response to aerobic exercise in
postmenopausal women with osteoporosis. An experimental, crossover, within-subject
study design was used where participants serve as their own control and complete both
exercise conditions. Conditions were counterbalanced, with participants randomly
assigned to start with one of the two conditions: 1) aerobic exercise while wearing the
exercise suit (ES), or 2) aerobic exercise without the exercise suit (NS). Participants
completed the different conditions on two different days, separated by a washout period
of a minimum of 7 days. Biochemical markers of bone turnover, P1NP, P1CP, and CTX,
were measured 15 minutes prior to the exercise bout, and at 24 and 72 hours post
exercise.

Participants
Participants were recruited from the faculty of California Polytechnic State
University, San Luis Obispo (Cal Poly) and the surrounding communities. To determine
eligibility, participants completed a brief telephone interview and the Canadian Society
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for Exercise Physiology’s PAR-Q and YOU Physical Activity Readiness Questionnaire
(Appendix B) to determine their ability to engage in exercise.
Inclusion criteria included: 1) 45-65 years of age, 2) BMI ≥ 18.5-30, 3) good
health, assessed by a health history questionnaire, 4) ability to participate in 90 minutes
of walking activity without stopping assessed by PAR-Q, 5) menopause ≥ 6 months,
assessed by a health history questionnaire, 6) low bone density as assessed by a
preliminary DXA scan, 7) the ability to carry a maximum of 12lbs assessed during
preliminary testing, 8) classified as sedentary or lightly active in accordance with ACSM
guidelines, assessed by self-reporting, and 9) fit within the confinements of the suit
measurements (Table 3.1 and 3.2). Exclusion criteria included: 1) any history of
osteoporotic fracture, 2) metabolic syndrome, 3) musculoskeletal or orthopedic disorder
(Paget’s disease), 4) history of cardiovascular or pulmonary disease, 5) currently taking
antiresorptive agents or anabolic agents to treat osteoporosis, 6) currently receiving
estrogen or hormone replacement therapy, 7) smoking tobacco, 8) regularly engage in
over 300 minutes of moderate exercise per week or 150 minutes of vigorous exercise per
week, and 9) diseases and conditions that may cause additional bone loss (Office of the
Surgeon General, 2004), including:


Autoimmune disorders (Rheumatoid Arthritis, Lupus, Multiple Sclerosis,
Ankylosing spondylitis, Osteitis deformans, Osteochondroma, Osteosarcoma)



Digestive and gastrointestinal disorders (Celiac disease, Inflammatory Bowel
Disease, weight loss surgery, gastrectomy, gastrointestinal bypass procedures)



Endocrine or hormonal disorders (diabetes, hyperparathyroidism,
hyperthyroidism, Cushing’s syndrome, Thyrotoxicosis)
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Hematologic or blood disorders (Leukemia and lymphoma, multiple myeloma,
Sickle Cell disease, blood and bone marrow disorders, Thalassemia)



Neurological or nervous system disorders (Stroke, Parkinson’s disease, spinal
cord injuries)



Mental illness (depression, eating disorders)



Cancer or history of cancer (breast cancer and prostate cancer)



AIDS/HIV



Kidney or liver disease



Organ transplants



Polio and post-polio syndrome

Because males experience bone loss at a slower rate compared to females, this study
only assessed women. All inclusion and exclusion criteria were be self-reported, assessed
by a Premier Performance, Inc. Health History Questionnaire (Appendix C) and the PARQ & YOU physical activity readiness questionnaire, or were objectively measured during
preliminary measurements. Participants were informed of all risks, benefits, and
requirements of the study, and gave verbal and written consent. All documentation and
procedures were approved by the Human Subjects Committee at Cal Poly.

Table 3.1: Exercise Suit Jacket Measurements
Medium
Chest (in)
17
Shoulder (in)

Large
18

16.5

17

Length (in)

28

29

Sleeves (in)

25

25
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Table 3.2. Exercise Suit Pants Measurements
Medium
Inseam (in)
29
Outseam (in)
37
Waist (in)
Hips (in)

26 (relaxed) – 34 (stretched)
38

Large
30
37.5
28 (relaxed) – 35 (stretched)
39

Screening and Informed Consent
Any woman who expressed interest in the study was given a general overview of
the study and its requirements. To determine eligibility, interested women completed a
brief telephone interview, which included a health history questionnaire and the PAR-Q
& YOU, to screen for their ability to begin engaging in exercise.
Eligible participants were asked to schedule an in-person visit to the Webb
Human Performance Laboratory in the Kinesiology Department at Cal Poly. During this
visit, the participant was asked to confirm their answers on the PAR-Q & YOU and
healthy history questionnaires, as well as complete several objective assessments to
further confirm eligibility. These assessments were designed to 1) determine if the
participant is able to fit within the confines of the exercise suit, and 2) assess whether the
participant could carry 12lbs.
Finally, participants had their DXA (GE Lunar iDXA, GE Healthcare, Bucks,
UK) scan scheduled by the primary researcher and completed to determine current Tscore, BMD, and body composition. DXA scans were completed in the Nutrition and
Health Assessment Laboratory at Cal Poly by a certified technician.
Once participant eligibility was confirmed, the study was explained in detail,
including the importance of fasting prior to exercise testing bouts, and attending all
assessments and follow up blood draws. The study and consent forms were reviewed and
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informed consent was obtained both verbally and through an informed consent document
(Appendix A).

Figure 3.1: Uniformly Weighted Exercise Suit (Curry,
Davis, Nazmi, & Clegg, 2015)

Experimental Conditions
Exercise Suit (ES) versus No Suit (NS)
The experimental conditions consisted of either 1) wearing the weighted exercise
suit (ES) or 2) no suit (NS) during a bout of aerobic exercise. During both conditions
participants wore clothes of their choice, preferably a t-shirt and athletic shorts with
athletic shoes. During the ES condition, the participant additionally wore the uniformly
weighted exercise suit designed by Dr. Lawrence Petrakis, MD, weighing 5.44kg (Figure
3.1). The exercise suit consisted of a front zip, full-sleeved jacket, and long, drawstring
pants. The fabric, AthlotexTM is uniformly weighted, and combines flexibility and
breathability for participant comfort as well as to accommodate various body
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compositions of the participants. Stainless steel beads are uniformly distributed and
integrated throughout the fabric, which is composed of Spandex and other synthetic and
natural fibers. A sample of two different participant timelines can be found in Table 3.3.

Table 3.3. Example Schedule of Events for Two Different Participants
Preliminary
Experimental Conditions1
Measures
Visit 1
Visit
24hr
72hr
Visit 24hr
72hr
2
post
post
3
post
post
test
test
test
test
Participant
Screening Blood Blood Blood
Blood Blood Blood
1
and
draw; draw
draw
draw; draw
draw
Informed
ES
NS
7 day
Consent
washout
Participant
Screening Blood Blood Blood period Blood Blood Blood
2
and
draw; draw
draw
draw; draw
draw
Informed
NS
ES
Consent
Exercise Suit (ES): exercise bout with suit, No Suit (NS): exercise bout without suit
1
Note that conditions are counterbalanced across the 2nd and 3rd visit

Experimental Protocol
Participants completed two identical single-bout exercise trial protocols in a
counterbalanced fashion, on two separate occasions separated by seven days (Tosun et
al., 2006). The only difference between trials was the addition of the exercise suit.
Participants were randomized to begin with one of the two conditions: 1) aerobic exercise
while wearing the exercise suit, or 2) aerobic exercise without the exercise suit.
Participants were asked to arrive at the Webb Human Performance Laboratory between
0700-1000 hours after an overnight fast, well rested, and well hydrated. Fasting status
was required due to a feeding effect of serum CTX. CTX can decrease by as much as
20% following a meal (Vasikaran, Eastell, et al., 2011). Participants were asked to
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consume 16-20oz of water the night before to ensure adequate hydration. Furthermore, all
participants were asked to refrain from exercise 72 hours prior to any and all sessions;
and caffeine, drugs, and alcohol for 24 hours prior to any and all sessions.
Upon arrival, the participant had their baseline blood drawn by the on-site
phlebotomist. Next, all physical activity, dietary, and hydration measures were assessed
though the completion of the International Physical Activity Questionnaire (IPAQ)
(Appendix D), and Automated Self-Administered 24-hour Dietary Recall (ASA24)
(Appendix E). To ensure proper hydration during and post exercise, participants were
given a 16oz water bottle to be consumed at will during their appointment. Participants
remained fasted until the exercise bout had been terminated.
Following completion of both questionnaires, and prior to the exercise bout,
participants had their resting heart rate, resting blood pressure, height, weight, BMI, and
tympanic membrane temperature measured and recorded (Appendix F). Resting heart
rate was measured using a PolarTM T31 transmitter and receiver (PolarTM, model
94035939.02), and blood pressure was measured using sphygmomanometry. A portable
stadiometer (SECA, Hamburg, Germany) was used to determine height to the nearest 0.1
centimeter and a digital scale (MedWeight digital scale, model MS-3200) was used to
determine weight to the nearest 0.1 kilogram. BMI was calculated using the following
equation: BMI = weight [kg]/height [m]2. Tympanic membrane temperature was recorded
using the BRAUN ThermoScan tympanic thermometer. Prior to the exercise bout, each
participant’s maximal heart rate range was determined using the Age Predicted
Maximum Heart Rate equation (220-age) in order to maintain the desired heart rate range
(Tosun et al., 2006). 65-75% HRmax was chosen to approximate a workload greater than
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that of activities of daily living, but low enough so as to not overstress the participant
(Moldover & Bartels, 2000).
The participant was fitted with headgear and a mouthpiece hooked up to a 6-foot
tube attached to the TrueOne 2400 metabolic measurement system (Parvo Medics,
Sandy, Utah) using a Hans Rudolf 3813 (Kansas City, MO) pneumotachometer to
measure ventilation during the first 15 minutes of the exercise bout. Before initializing
the exercise bout, the gas analyzer was calibrated to the manufacturer’s specifications,
including a room air auto-calibration and a two-point gas calibration using a single gas
tank. To calibrate the flow meter, a 3L Hans Rudolf 5530 series syringe was used,
involving a series of flow rate stroke calibrations (Crouter, Antczak, Hudak, DellaValle,
& Haas, 2006).
Participants walked on a treadmill (Trackmaster, Full Vision Inc., Newton,
Kansas; Q 65, Quinton Instrument Company, Seattle, Washington) with the necessary
incline and grade to elicit the desired heart rate range. Gas analysis was performed using
a computerized TrueOne 2400 metabolic measurement system (Parvo Medics, Sandy,
Utah) using a Hans Rudolf 3813 (Kansas City, MO) pneumotachometer to measure
ventilation. Participants wore a nose clip and headgear, which secure the 1-way Hans
Rudolf valve to the rubber mouthpiece, during the first 15 minutes of the exercise bout to
test for oxygen and carbon dioxide analysis. Additionally, the gas analysis allowed for
the calculation of time necessary to reach caloric expenditure.
After the first 15-minutes, the participant was instructed to remove the nose clip
and headgear, and to continue walking for the remainder of the trial. Total duration of the
exercise session was calculated by averaging the caloric expenditure over minutes 10-15,
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during steady state, to determine the average caloric expenditure per minute. The total
energy expended was subtracted from the goal expenditure (400kcal), to establish the
remaining time necessary to burn the remaining calories. Heart rate was measured before
and monitored during the trial, at 5-minute intervals until the cessation of the trial, to
ensure the participant remains within the target heart rate range. Blood pressure was
measured halfway through the exercise bout, and twice following the exercise bout to
ensure adequate recovery. Tympanic membrane temperature was recorded prior to and
during the exercise bout, at 25-minute intervals. The timeline of required action during
the exercise bout can be referenced in Table 3.4. During both trials, the participant was
cooled by a fan placed behind and to the left of the treadmill.

Table 3.4. Timeline of Participant Action During Exercise Trial Duration By Minute
Minute
Participant Action
0-10
Walking to reach steady state
10-15

Steady state achieved; calculate calories per minute
expended during steady state to predict duration of trial

15

Remove headgear and nose clip

15 – termination of exercise

Continue walking at the same pace and incline

Criteria for terminating the exercise trial prematurely followed ACSM guidelines
for general indications for stopping an exercise test in low-risk adults (American College
of Sports Medicine, 2013): 1) onset of angina-like symptoms, 2) drop in systolic blood
pressure of > 10 mm Hg from baseline blood pressure (BP) despite an increase in
workload, 3) excessive rise in BP: systolic pressure > 250 mm Hg or diastolic pressure >
115 mm Hg, 4) shortness of breath, wheezing, leg cramps, or claudication, 5) signs of
poor perfusion: light-headedness, confusion, ataxia, pallor, cyanosis, nausea, or cold and
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clammy skin, 6) failure of heart rate to increase with increased exercise intensity, 7)
noticeable change in heart rhythm, 8) subject request to stop, 9) physical or verbal
manifestations of severe fatigue, or 10) failure of testing equipment.
Following normal termination of the exercise bout, a post-weight was taken to
assess hydration status of the participant, and she was again offered 16oz of water. The
participant returned to Cal Poly 24 hours and 72 hours post exercise to have her follow up
blood draws taken at the same time as the baseline blood draw. As stipulated previously,
the participant was overnight fasted, well hydrated, and had not performed additional
exercise within the last 24 hours.
One week later, the participant returned to the Webb Human Performance
Laboratory at Cal Poly to complete the identical protocol following the subsequent
experimental condition, including baseline blood draw, followed by the 24 hour and 72
hour follow up blood draws.

Blood Measures
Blood was drawn by one of two trained phlebotomists at Cal Poly 15 minutes
before the exercise session (baseline), 24 and 72 hours following the submaximal aerobic
exercise. Blood was collected in a BD 367988 vacutainer Plus SST Plus Venous Blood
Collection Serum Tube (BD Biosciences), and left to sit for 15-30 minutes at room
temperature until the blood clotted. The clot was removed by centrifuging the sample at
2,000 x g for 15 minutes in a refrigerated centrifuge (Sorvall ST 40R Centrifuge, Thermo
Fisher Scientific, 2012). Immediately following centrifugation, the serum was transferred
into a clean polypropylene cryovial tube using a Pasteur pipette. Serum samples were
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stored at -80˚C for later simultaneous analyses. All calibrators, controls, and samples of
P1NP, P1CP, and CTX were measured in triplicate samples of serum by enzyme-linked
immunosorbent assay (NeoScientific, NeoGroup Inc, Cambridge, MA) according to
manufacture specifications and instructions (Appendix G).
All serum samples and kit components were brought to room temperature prior to
use. In order to prepare the reagents, 10µl of Balance Solution was dispensed into
100µl of the experimental samples. The following assay procedure was utilized with all
samples. One hundred microliters of the sample or standard was dispensed into the
appropriate number of wells in the NeoPlate, and 100µl of deionized water was added to
the pre-determined blank wells. An enzyme solution (50µl) was then dispensed into each
well, except the blank wells. Following 1-hour of incubation, each well was washed 5
times with 300-400µl of 1x wash solution per well. Substrate A (50µl) was added to each
well, followed by an addition of 50µl of Substrate B. Again, the plate was covered and
incubated for 15 minutes. Finally, 50µl of stop solution was dispensed into each well and
mixed well. Immediately following, the plate was read, using a Fisher Scientific
Multiskan FC Microplate Reader (Fisher Scientific) to determine the optical density
(O.D.) at 450nm. The mean blank value was subtracted from each sample or standard
value, and the mean for triplicate wells was calculated. Standard curves were constructed
using statistical software.
The primary investigator analyzed all serum samples to prevent interpretation
errors. The degree to which the samples, in triplicate, differ can be explained by
calculating the intra-assay Coefficient of Variability (CV). It was calculated as follows:
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Eq. 1

CV (%) = (SD of triplicate sample/Mean of triplicate sample)*100
Overall Plate Intra-assay CV (N= number of triplicate samples) =
Mean of all Intra-assay CVs

The corresponding concentrations of each biomarker were reported to reflect the
range of results found within the sample specimens. Overall plate intra-assay CV is a
measure of the mean of all the intra-assay CV’s for each sample. A measure of less than
10% was acceptable (Chesher, 2008). The intra-assay CV was 8.64% at 1.7 ng/L, 6.79%
at 4.4 µg/L, and 7.28% at 1.4 µg/L, for P1NP, P1CP, and CTX, respectively.

Sample Size Calculation
The sample size was based on Thorsen et al. (1996), which showed an increase in
P1CP as a result of exercise, at 24 hours and 72 hours, relative to baseline. With 9
participants, our within-subject, experimental, crossover design, using a two-sample, twosided t-test, α <0.05 had 80.5% to detect a difference in P1CP serum levels between rest
and 24 hours post exercise bout, and a 93.5% power to detect a difference in P1CP serum
levels between rest and 72 hours post exercise.

Statistical Methods
All statistical analyses were performed using JMP Stats version 12 (SAS Institute,
Cary, NC) statistical software. Descriptive statistics were calculated for participant
characteristics, including means and standard deviations (SD). Dependent t-tests were
used to compare the means of the differences of the baseline participant characteristics
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for each condition. Repeated Measures Analysis of Variance (ANOVA) was used to
assess the independent effects of time (the effect of exercise), condition order (which
condition participants experienced first), and condition x time interactions for P1NP,
P1CP, and CTX. Exploratory analyses were utilized to evaluate biomarker changes
separately within each condition. Given the equal sample sizes per comparison group,
Tukey’s post hoc analysis was used to determine any differences in biomarker changes
from baseline, and between time points. A significance level of P<0.05 was used for all
comparisons.
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Chapter IV
RESULTS

Participants
Participant characteristics for age (years), height (cm), body weight (kg), body
mass index (BMI), BMD T-score, and BMD Z-score were reported in means and
standard errors in Table 4.1. All participants presented with low BMD as characterized
by a negative T-score.

Table 4.1. Participant Characteristics (N=9)
Mean
Age (years)
58.7 (3.4)

Range
52.0-63.0

Height (cm)

165.9 (7.3)

154.9-180.3

Weight (kg)

77.7 (9.3)

64.6-89.8

BMI (kg·m )

28.2 (3.1)

23.4-32.3

BMD T-score

-1.2 (1.0)

-2.7- -0.5

BMD Z-score

0.3 (1.6)

-2.3-2.7

-2

Note: Values are Mean (SD)

A comparison of the mean of the difference of the baseline characteristics for
participants prior to the start of each exercise condition were analyzed (Table 4.2).
Dependent t-tests revealed there was no significant difference between the means for
caloric intake 24 hours prior to the exercise session, resting systolic blood pressure,
resting diastolic blood pressure, height, weight, tympanic membrane temperature, or time
to goal expenditure of 400kcal. There was, however, a significant difference for resting
heart rate (P=0.04). These results indicate that participants presented with higher resting
heart rates, on average, prior to the exercise session without the suit.
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Table 4.2. Comparison of Characteristics at Baseline for Each Condition
Exercise
No Suit
Range
tSuit (ES)
(NS)
value
Caloric Intake 24 hours
1518.2
1520.2
994.6-2521.6 0.01
prior
(732.6)
(546.4)

p-value
0.99

Resting Heart Rate (bpm)

70.2
(7.1)

78.7
(8.5)

60.0-87.0

2.28

0.04

Resting Systolic Blood
Pressure (mmHg)

125.8
(3.5)

125.4
(6.6)

118.0-138.0

-0.10

0.90

Resting Diastolic Blood
Pressure (mmHg)

78.0
(9.4)

77.8
(3.2)

60.0-92.0

-0.06

0.90

Weight (kg)

165.6
(9.9)

166.1
(9.7)

64.5-92.2

-0.06

0.99

Body Mass Index (BMI)

28.9
(3.1)

28.6
(2.9)

23.4-32.3

-0.20

0.80

Tympanic Membrane
Temperature (F)

97.8
(0.5)

97.5
(0.9)

96.2-98.7

-0.80

0.40

Time to Goal Expenditure
(min)

52.5
(4.8)

55.6
(5.9)

42.0-62.0

1.30

0.20

Final Speed

3.1
(0.5)

3.1
(0.5)

2.1-3.6

0.00

0.99

Final Incline

2.4
(1.1)

2.4
(1.1)

0.5-4.0

0.00

0.99

Note: Values are Mean (SD)

Changes in Biochemical Markers for Bone Turnover
It was hypothesized that, when compared to the non-suit condition, wearing the
5.44kg weighted exercise suit during submaximal aerobic exercise to goal expenditure
(400kcal), would elicit a greater positive change in P1NP and P1CP, and a greater
negative change in CTX at both 24 and 72 hours post-exercise relative to baseline. The
changes in biochemical markers of bone turnover over time are shown in Table 4.3 and
Figures 4.1-4.3.
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Table 4.3. Measurements of Serum Amino-Terminal Propeptide of Type 1 Collagen
(P1NP), Carboxy-Terminal Propeptide of Type 1 Collagen (P1CP), and CarboxyTerminal Telopeptide of Type 1 Collagen (CTX) at Baseline, 24 hours, and 72 hours Post
Exercise
Exercise Suit
No Suit
Baseline
24hrs
72hrs
Baseline
24hrs
72hrs
P1NP
10.6
12.1
10.9
10.5
12.4
11.0
(ng/L) (2.1)
(3.6)
(2.4)
(2.3)
(5.1)
(2.6)
P1CP
(µg/L)

10.5
(2.1)

13.3*
(3.4)

9.9
(2.1)

10.2
(4.1)

10.4
(4.3)

9.3
(3.9)

CTX
(µg/L)

8.5
(2.4)

8.9
(2.4)

8.7
(2.6)

8.8
(2.3)

12.7*
(5.1)

9.9
(1.9)

Values are Mean (SD)
Significantly different from baseline: *P<0.05
NS, aerobic exercise without the exercise suit;
ES, aerobic exercise while wearing the exercise suit
P1NP, Amino-Terminal Propeptide of Type 1 Collagen; P1CP, Carboxy-Terminal
Propeptide of Type 1 Collagen; CTX, Carboxy-Terminal Telopeptide of Type 1 Collagen

There was no effect of time (P=0.26), order of experimental condition (P=0.89),
or condition (P=0.96) on change in serum levels of P1NP at any time point relative to
baseline (Figure 4.1). Moreover, there was no effect of an interaction between condition
and time (P=0.99) on P1NP levels at any given time point. Post hoc analysis revealed no
difference between conditions (P=0.98). These finding suggests there was no significant
effect of this type of submaximal aerobic exercise on serum levels of P1NP.
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16

Mean P1NP (ng/L)

14
12
10
8

ES

6

NS

4
2
0
0

24
Time (hours)

72

Figure 4.1: Effect of Condition (ES; exercise suit, NS; no suit) on Average Serum
Level of Amino-Terminal Propeptide of Type 1 Collagen (P1NP) at Baseline, 24hours and 72-hours Post Exercise Session. Values are Mean ± SE.

A statistically significant effect of time (P=0.01) on P1CP levels was observed.
Participants’ serum P1CP values increased at 24 hours post exercise (P=0.01), but
returned to baseline levels at 72 hours (P=0.58). There was no observable effect of order
of trial condition (P=0.35). A statistically significant effect of condition on P1CP levels
was observed (P=0.04). ES caused a significant increase in serum P1CP values (P=0.01),
while NS caused no significant change (P=0.59). There was no effect of an interaction
between condition and time (P=0.19). However, further exploratory analysis, when the
effects of time were analyzed by condition, revealed a significant increase in serum P1CP
values from 0-24 hours was seen during the ES condition, but not during the NS
condition.
The mean increase in P1CP at 24 hours post exercise, compared to baseline levels
was 27.2% and 2.30% for ES and NS, respectively (Figure 4.2). These findings indicate
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that this type of exercise was substantial enough to elicit a significant response in serum
levels of P1CP only while wearing the weighted exercise suit.

16

*

Mean P1CP (µg/L)

14
12
10
8
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0
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72

Figure 4.2: Effect of Condition (ES; exercise suit, NS; no suit) on Average Serum
Levels of Carboxy-Terminal Propeptide of Type 1 Collagen (P1CP) at Baseline, 24
hours and 72 hours Post Exercise Session. All values are Mean ± SE. *Significant
change from baseline to 24 hours during ES condition: P<0.05.

There was no effect of time (P=0.89) or of order of condition (P=0.29) on serum
levels of CTX in response to this type of exercise. Statistically significant variances due
to condition were observed in levels of CTX (P=0.001). There was evidence of a
significant interaction between condition and time (P=0.02). Tukey’s post hoc analysis
revealed a significant difference between conditions at 24 hours following exercise
(P=0.001). A significant increase in CTX values was seen after the NS condition
(P=0.0003), but not after the ES condition (P=0.89). The mean increase in CTX at 24
hours, compared to basal levels, was 5.3% and 44.7% for ES and NS, respectively
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(Figure 4.3). These findings suggest an antiresorptive effect of wearing the weighted
exercise suit on markers of bone resorption.
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Mean CTX (µg/L)

14
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10
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0
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72

Figure 4.3: Effect of Condition (ES; exercise suit, NS; no suit) on Average Serum
Levels of Carboxy-Terminal Telopeptide of Type 1 Collagen (CTX) at Baseline, 24
hours and 72 hours Post Exercise Session. Values are Mean ± SE. *Significant change
from baseline to 24 hours during NS condition: P<0.05. ‡Significant difference between
ES and NS conditions at 24 hours: P<0.05.
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Chapter V
DISCUSSION AND CONCLUSION

Discussion
The purpose of the present study was to examine the effects of a uniformly
weighted exercise suit on serum biochemical markers of bone formation (P1NP, P1CP)
and resorption (CTX) in response to submaximal aerobic exercise in postmenopausal
women with low bone density. It was hypothesized that, when compared to the non-suit
condition (NS), wearing the uniformly weighted exercise suit (ES) during submaximal
aerobic exercise would elicit a greater: positive change in P1NP at 24 and 72 hours post
exercise relative to baseline; positive change in P1CP at 24 and 72 hours post exercise
relative to baseline; and negative change in CTX at 24 and 72 hours post exercise relative
to baseline. Results suggest that submaximal aerobic exercise under ES conditions may
be beneficial for bone health, as the ES condition provided a significant stimulatory effect
on P1CP combined with an antiresorptive effect on levels of CTX when compared to the
NS condition. No effect of exercise or condition on P1NP was seen at any time point.
Fibrillar collagen synthesis, characterized by the cleavage of P1NP and P1CP
from the procollagen molecule during bone matrix formation (Kadler et al., 1996),
indicates an increase in the circulation of these biomarkers. Previously literature suggests
a significant association between fracture risk and bone formation markers, showing
lower circulating levels of P1CP were associated with higher fracture rates (Akesson et
al., 1995; Vasikaran, Eastell, et al., 2011). Our findings show that, 24 hours following
exercise during the ES condition, there were increased levels of P1CP, indicating an
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increase in this formation process. The lack of similar results following the NS condition,
suggests the stimulatory effect on collagen synthesis results only while wearing the
weighted exercise suit. Our findings suggest that wearing the weighted exercise suit
during submaximal aerobic exercise may have the potential to decrease risk for fracture
within this population.
Possibly the most impactful results of the present study were those associated
with variance in serum levels of CTX. During bone resorption, collagen peptide
fragments are secreted into circulation, and a rise in CTX is expected. Our findings
indicated a significant within-person increase in CTX levels during exercise in the NS
condition, and a distinct lack of variance during the ES condition. The lack of increase in
collagen resorption during the ES condition, when compared to the NS condition, suggest
an acute antiresorptive effect of weighted aerobic exercise on bone collagen due to the
increased loading on the musculoskeletal system (Knapik et al., 1996; Kohrt, 2001).
To our knowledge, no other study has investigated the effects of short-term, low
impact aerobic exercise on variance in CTX. However, many have investigated the
effects of exercise on the amino-terminal telopeptide of type 1 collagen (NTX).
Significant decreases in NTX, due to submaximal treadmill walking exercise, have been
observed in several studies (Roghani et al., 2013; Yamazaki et al., 2004). However,
previous research suggests NTX, when compared to CTX, may lack specificity to bone
due to the smaller response to intervention therapy (Vasikaran, Eastell, et al., 2011).
There appears to be a more significant association between fracture risk and
markers of bone resorption, when compared with bone formation (Vasikaran, Eastell, et
al., 2011). When data from six previous publications (Bauer et al., 2009; Chapurlat,
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Garnero, Breart, Meunier, & Delmas, 2000; Dobnig et al., 2007; Garnero, Sornay-Rendu,
Claustrat, & Delmas, 2000; Gerdhem et al., 2004; Meier, Nguyen, Center, Seibel, &
Eisman, 2005) investigating the association between serum levels of CTX and fracture
risk in olden men and women were merged, the results indicated that a 1 SD increase of
CTX was equivocal to an 18% increase in risk for fracture (Johansson et al., 2014). If the
reverse of this association holds as expected, it would suggest that decreasing levels of
CTX should, in turn, decrease fracture risk in the same population.
The increase in markers of bone formation in response to low impact aerobic
exercise seen in the current and previous studies may be attributable to the additional load
placed on the musculoskeletal system by the exercise suit. As Wolff’s law suggests, bone
growth and remodeling occur in response to the forces placed upon it (Sinaki, 1989), so
loading the skeleton with the additional weight provided by the exercise suit would be
expected to cause a physiological reaction favoring bone formation to support the new
load. Furthermore, the uniform design of the weighted suit allows for weight to be
distributed over a greater surface area of the body, increasing the regions that can be
affected by the external load. Biomarkers of bone formation and resorption are systemic,
not site specific, suggesting the greater affected surface area could cause a more
widespread effect. Although the systemic nature of biomarkers is advantageous in the
present study, it doubles as a limitation. It is unclear as to where the formation and
resorption are occurring within the body. Previously research suggests interventions have
focused primarily on increasing BMD in the lumbar spine and hip to prevent fracture.
Future research utilizing both DXA and biomarkers of bone turnover should investigate

62

locations of bone modeling or resorption in response to externally loaded aerobic
exercise.
The beneficial effects of the weighted suit seen in the present study have various
physical and psychosocial health related implications for the target population. The
combination of increased formation and decreased resorption, if maintained over time,
have the potential to slow the rate of BMD loss, thus decreasing fracture risk amongst
postmenopausal women with low bone density, even before changes in BMD occur
(Bonnick & Shulman, 2006). Further possible benefits, which should be explored in
future research, include improved balance (Roghani et al., 2013; J. M. Shaw & Snow,
1998), better posture (Harman et al., 1994; Kinoshita, 1985), improved indices of fall
risks, lower body muscular strength, and muscular power (Snow et al., 2000), and
maintenance of normal gait patters, which can be negatively affected by BMD loss
(Lloyd & Cooke, 2011).
It remains unclear as to why significant variance was observed in P1CP but not
P1NP, as we would have expected to see the same variance, or lack thereof, in both
collagen metabolites. During the type 1 collagen formation, P1CP and P1NP are cleaved
from the ends of the pro-collagen molecule in equimolar concentrations (Kadler et al.,
1996) (Figure 2.3). This process occurs prior to formation of the collagen fibril,
suggesting the production of serum P1CP and P1NP reflect the rate of collagen formation
on a stoichiometric basis (Adler, 2009; Delmas et al., 2000; Eriksen et al., 1993). While
no international reference standard currently exists for P1CP, our P1NP data falls within
normal reference intervals for healthy postmenopausal women (Eastell, Krege, Chen,
Glass, & Reginster, 2006; Vasikaran, Eastell, et al., 2011). Research should regularly
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monitor levels of P1NP, as an increase greater than or equal to 21% from baseline
indicates an adequate response due to intervention therapy (Eastell et al., 2006).
Research by Thorsen et al. (1996) investigated the effects of non-weighted brisk
walking on the amino-terminal propeptide of type III collagen in serum (PIIINP) and
found brisk walking also increased levels of PIIINP at 24 and 72 hours post-exercise.
Although change was observed in this variant of P1NP, PIIINP and P1NP are indicative
of different metabolic processes, suggesting inferences cannot be made between the
observed increase in one to the other. Type III (PIIINP) collagen is derived from type III
procollagen, a much larger protein when compared with type 1 procollagen.
Concentrations of PIIINP increase in response to the accumulation or breakdown of
connective tissue, most often related to fibroproliferative, endocrinological, malignant,
and hematological diseases (Ehlers & Leary, 2008). While neither type I nor type III
collagen are exclusively specific to bone, roughly 90% of the organic matrix and 35% of
bones dry weight is made up of type 1 collagen (Vasikaran, Eastell, et al., 2011). Thus,
the IOF and IFCC have recommended that variance of bone turnover should be measured
utilizing type 1 collagen metabolites (P1NP, P1CP).
Due to the inconsistency in both variance between P1NP and P1CP, and the lack
of findings at 72 hours, future studies should explore the duration of stimulated
physiological effects, and should strongly consider measuring serum P1NP and P1CP at a
time interval between 24 and 72 hours post exercise to better understand patterns of
P1NP and P1CP variance after exercise. In order to utilize the exercise suit to maximize
osteogenic response during exercise, determining the greatest window of physiological
stimuli would be vital to determine the optimal timing for multi-session interventions.
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Future research investigating the effects of the weighted exercise suit should also
address the limitations of the present study. Inconsistency in measures of bone formation
and lack of evidence of variance in any biomarker at the 72 hour time point suggest
limitations of the current study in terms of frequency, intensity, type of exercise,
duration, or limitations imposed by the exercise suit. Future research investigating
biomarkers of bone turnover should also include measuring intensity levels via serum
cortisol, to accurately determine the levels of physical stress experienced, due to exercise,
at all time points. This would allow for a more comprehensive analysis of the effects of
duration versus intensity on variance in biomarkers. The findings from this analysis
would be beneficial for exercise prescription for persons concerned with bone health.
Additional study design limitations include the lack of objectively measuring
physical activity levels throughout the entirety of the study duration. Future studies
should consider utilizing pedometers or accelerometers to monitor participant physical
activity levels to ensure similar patterns throughout the study. Increased physical activity
levels during the washout period have the potential to affect both baseline measurements
for the second trial and follow up measures depending on the intensity of the activity, as
seen by alterations in biomarker levels as early as 24 hours post exercise.
Moreover, the participant’s psychological states or motivations may have affected
her physical activity levels or nutritional intake pattern outside of testing sessions. The
Hawthorne effect has been well documented and suggests that participants in an
experiment may change their behavior simply because they are being monitored (Bravata
et al., 2007; Campbell, Maxey, & Watson, 1995; Katz, 2008). Participating in a health
related study could cause the participant to want to change their behavior. Further
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research should consider having participants keep a nutritional journal to ensure no major
deviations are made from their normal eating patterns.
The present study was powered only for P1CP, due to the lack of previous data on
the new standard set of biomarkers (P1NP, CTX) during short-term exercise, disallowing
for this analysis to be done for each. Although the study was powered at greater than 80%
for the given sample size, a greater sample size in future research may result in
understanding the effects of submaximal aerobic exercise, under both conditions, on
serum levels of P1NP across all time points. Additionally, the greater sample size could
provide further information regarding the trend of decline in all markers back to baselinelike values from 24 hours to 72 hours post exercise. Future research should strongly
consider recruiting a greater number of participants to explore these trends.
Finally, our study design was limited by the standard weight of the exercise suit.
Future research utilizing the weighted exercise suit should consider weighting each
participant by a standard percent of their body weight, rather than loading all participants
with a constant weight. Loading by percent body weight would provide the same external
loading stimulus. It is possible that while the 5.44kg suit provided enough of an
osteogenic stimulus for some participants, it was not heavy enough to produce the same
effect in others. As noted previously, the lack of sufficient load could have affected
biomarker data, leading to findings of no variance.

Conclusion
In conclusion, wearing the uniformly weighted exercise suit during submaximal
aerobic exercise (65%-75% age predicted maximum heart rate) to goal expenditure of
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400kcal, increased serum biochemical markers of bone formation (P1CP), while
simultaneously providing an antiresorptive effect on biochemical markers of bone
resorption (CTX) at 24 hours following exercise. The identical exercise protocol,
completed without the exercise suit, did not elicit the same response; CTX was increased
significantly in the non-suit condition, while P1CP showed no variation. From a clinical
perspective, increasing formation, while limiting resorption, may provide significant
benefits to postmenopausal women with low bone density in terms of decreased risk for
fracture.
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Appendix A
Informed Consent Form
INFORMED CONSENT TO PARTICIPATE IN A RESEARCH PROJECT, “The
Effects of a Uniformly Weighted Exercise Suit on Biomarkers of Bone Turnover in
Response to Aerobic Exercise in Postmenopausal Women with Low Bone Density”
Who is conducting this study and what is the purpose?
A research project on bone metabolism is being conducted by Haley Terndrup, Dr.
Alison K. Ventura, and Dr. Todd Hagobian, from the Department of Kinesiology at Cal
Poly San Luis Obispo, and Dr. Scott Hazelwood from the Department of Biomedical
Engineering at Cal Poly. The purpose of this study is to examine the effects of wearing a
weighted exercise suit on bone metabolism biomarkers in response to aerobic exercise in
a sample of postmenopausal women.
What are you being asked to do, and where?
You are being asked to take part in this study by visiting our laboratory for two
experimental trials, and four follow up blood draws. First, you will have baseline
measurements taken, including your height and weight, resting heart rate, resting blood
pressure, and temperature. Per the two exercise trials, the condition you start with will be
determined purely by chance. The two conditions are 1) aerobic exercise while wearing
the weighted exercise suit, or 2) aerobic exercise without the weighted exercise suit.
The protocol is as follows:
 1 baseline blood draw
 Fill out two questionnaires (International Physical Activity Questionnaire and
Automated Self-administered 24-hour Recall)
 Short-term exercise bout
All events will take place in the Webb Human Performance Lab of the Kinesiology
Building (43A-250) on Cal Poly Campus. Twenty-four and 72 hours after your exercise,
you will be asked to return to Cal Poly for successive blood draws. The second trial will
follow an identical protocol, but your exercise condition will be opposite. Prior to the first
exercise trial, you will complete a body composition and bone mineral density (Dual
Energy X-ray Absorptiometry) scan.
What occurs during the exercise trial?
You should wear shorts and a t-shirt for both exercise trials and you should arrive having
not eaten yet that day. You will be asked to walk on a treadmill at an incline and speed
necessary to maintain working at 65-75% of your calculated maximum heart rate. The
exercise trial will end once you have expended 400 calories. You will be exercising for
roughly 60-90 minutes. This exercise will consist of a 15 minute warm up period to
establish a constant rate of work, followed by roughly 45-75 minutes of walking at the
same pace until the goal has been reached. .
How long will the study last?
The expected total amount of time required to participate in this study is approximately 78 hours maximum, a period of two weeks. Please be aware that you are not required to
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participate in this research and you may discontinue your participation at any time
without penalty.
What are the possible risks?
The risk involved in this study is minimal. The possible risks associated with
participation in this study include physical and psychological risks. Physical risks include
those that are inherent to participating in any type of low-intensity exercise: falling, pain,
discomfort, muscle soreness, injury, dizziness, dehydration, hunger, headache, tingling,
hyperthermia, and in rare cases, nausea, vomiting, or heart attack. The possible
psychological risks include: potential discomfort during different aspects of the exercise
trial (dislike of wearing the weighted suit; awkwardness of wearing the headgear and
mouthpiece). You may also experience psychological discomfort from having to exercise
in front of the experimenter, getting weighed and measured, answering questions about
your current and past health, and/or prematurely requesting termination of the exercise
trial. Additionally, they may result from persons being uncomfortable with blood. If you
should experience any of the negative physical, emotional, or social outcomes as
described above, please be aware that you may contact Haley Terndrup at (650) 353-0677
or hterndru@calpoly.edu for assistance. If you are a Cal Poly employee, you may also
contact the Cal Poly Health and Counseling Services at (805) 756-2511. There will be at
least two certified CPR, AED, and First Aid certified researchers or assistants present
during your assessments and exercise sessions in case of injury or emergency.
What are the possible benefits?
We cannot promise any benefits to from taking part in this research. However, potential
benefits associated with the study include acute physical and psychological outcomes.
Physical benefits may involve increased muscle strength, endurance, and metabolism.
Psychological benefits may involve increased confidence, motivation, satisfaction, and
heightened social interaction. Furthermore, you will be testing new exercise technology
that has potential to enhance the benefits associated with physical activity and/or
exercise. Participating in this study will allow the researchers to receive a better
understanding of how the exercise suit influences one’s blood serum bone turnover
markers.
What happens to the information we collect?
The primary investigator has attended Data Security Training, and has been familiarized
with CSU guidelines, and rules on saving and transporting data. Your confidentiality will
be protected by removing any questionnaire face sheets containing identifying
information; code numbers will be used in place of names; the individuals with access to
data containing identifiers will be limited to the researchers identified on this form; and
data will be stored in locked cabinets and password protected devices.
What should you do if you have additional questions?
If you have questions regarding this study or would like to be informed of the results
when the study is completed, please feel free to contact Haley Terndrup at (650) 3530677 or hterndru@calpoly.edu. You may also contact Dr. Alison K. Ventura at
akventur@calpoly.edu. If you have concerns regarding the manner in which the study is
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conducted, you may contact Dr. Michael Black, Chair of the Cal Poly Human Subjects
Committee, at (805) 756-2894, mblack@calpoly.edu, or Dr. Dean Wendt, Dean of
Research, at (805) 756-1508, dwendt@calpoly.edu.
If you agree to voluntarily participate in this research project as described, please
indicate your agreement by signing below. Please indicate if you agree to have your
picture taken during exercise sessions for research purposes by signing below. These
pictures will be displayed for the exercise suit manufacturer and poster board
presentations. Lastly, please keep one copy of this form for your reference, and thank
you for your participation in this research.

_______________________________
Signature of Volunteer

______________
Date

_______________________________
Signature of Researcher

______________
Date

I agree to have my picture taken

Yes_____
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No_____

Appendix B
Canadian Society for Exercise Physiology’s Physical Activity Readiness Questionnaire
(PAR-Q) and YOU
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Appendix C
Health History Questionnaire
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Appendix D
International Physical Activity Questionnaire (IPAQ)
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Appendix E
Automated Self-Administered 24-hour (ASA24) Dietary Recall System
Description from the ASA24 website: http:// asa24.nci.nih.gov
Extensive evidence has demonstrated that 24-hour dietary recalls provide the highest
quality, least biased dietary data. Traditional 24-hour recalls, however, are expensive and
impractical for large-scale research because they rely on trained interviewers and
multiple administrations to estimate usual intakes. As a result, researchers often make use
of food frequency questionnaires, which are less expensive but contain substantial error.
To address this challenge, investigators at NCI created the Automated Self-administered
24-hour Recall (ASA24) system, a web-based tool that enables multiple automated selfadministered 24-hour recalls. ASA24 was developed under contract with Westat, a social
science research firm located in Rockville, MD, and builds on the Food Intake Recording
Software System (FIRSSt) developed by Dr. Tom Baranowski of the Baylor College of
Medicine. An External Working Group provided advice about the needs and interests of
potential users.
ASA24 consists of a Respondent Web site used to collect recall data and a Researcher
Web site used to manage study logistics and obtain data analyses. A Beta version
released in August 2009 and supported through June 2012 was used by more than 200
researchers to collect more than 45,000 recalls. ASA24-2011 (released in September
2011) and ASA24-Kids-2012 (released in September 2012) continue to be available for
currently registered studies but are no longer available for use to register new studies.
The current versions, ASA24-2014, ASA24-Kids-2014, and ASA24-Canada-2014 are
now freely available for use by researchers, clinicians, and teachers.

Figure 2: Prompt screen 1 from ASA24
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Appendix F
Exercise Protocol Data Sheet

Participant ID#____________
Date: ____________
Exercise Condition (ES/NS): _____________________
Age Predicted HR max (220-age): ________________
Baseline blood draw (date/time): ________________

Height (cm)

Weight (kg)

Temperature (F)

Pre-test
Post-test
Minute

Heart Rate
(bpm)

Blood Pressure
(mmHg)

Temperature (F)

Resting
5
10
15
20
25
50
75
100
125
150
POST 1
POST 2
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Incline
(%)

Speed
(mph)

Exercise Trial Comments:

24 hour follow up blood draw (date/time): ________________
72 hour follow up blood draw (date/time): ________________
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Appendix G
ELISA Kit Instructions
Amino-Terminal Propeptide of Type 1 Collagen (P1NP)
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Carboxy-Terminal Propeptide of Type 1 Collagen (P1CP)
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Carboxy-Terminal Telopeptide of Type 1 Collagen (CTX)
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